0001021561-14-000090.txt : 20140813
0001021561-14-000090.hdr.sgml : 20140813
20140813200716
ACCESSION NUMBER: 0001021561-14-000090
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140512
FILED AS OF DATE: 20140813
DATE AS OF CHANGE: 20140813
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NU SKIN ENTERPRISES INC
CENTRAL INDEX KEY: 0001021561
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 870565309
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: D. MATTHEW DORNY
CITY: PROVO
STATE: UT
ZIP: 84601
BUSINESS PHONE: 801-345-6100
MAIL ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: D. MATTHEW DORNY
CITY: PROVO
STATE: UT
ZIP: 84601
FORMER COMPANY:
FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC
DATE OF NAME CHANGE: 19960919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHANG JOSEPH Y
CENTRAL INDEX KEY: 0001184201
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12421
FILM NUMBER: 141039076
MAIL ADDRESS:
STREET 1: NU SKIN ENTERPRISES INC
STREET 2: 75 WEST CENTER
CITY: PROVO
STATE: UT
ZIP: 84601
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2014-05-12
2014-05-12
0001021561
NU SKIN ENTERPRISES INC
NUS
0001184201
CHANG JOSEPH Y
C/O NU SKIN ENTERPRISES, INC.
75 WEST CENTER STREET
PROVO
84601
0
1
0
0
Chief Scientific Officer
Employee Stock Option (right to buy)
77.65
2014-05-12
4
A
0
0
0
A
2014-05-12
2020-07-15
Class A Common Stock
0
0
D
On July 15, 2013, the reporting person was granted a performance-vesting stock option to purchase 50,000 shares of Class A Common Stock, which vests in four equal tranches based on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On May 12, 2014, the reporting person reported the vesting of 12,500 performance-vesting stock options based on the determination of the Issuer's Compensation Committee that the relevant performance criteria had been satisfied. However, due to the August 12, 2014 restatement of the Issuer's consolidated financial statements for the quarter ended March 31, 2014, the Issuer's Compensation Committee determined that the relevant performance criteria had not been satisfied and that the 12,500 performance-vesting stock options remain unvested and are not currently reportable. Accordingly, this amendment is being filed to eliminate the previously reported vesting.
Clayton A. Jones as Attorney-in-Fact for Joseph Y. Chang
2014-08-13